Structures of Endocrine-Disrupting Chemicals Determine Binding to and Activation of the Estrogen Receptor α and Androgen Receptor.
Level 5 - mechanism / opinion, no new human data
In silico computational modeling and in vitro bench study without human data
PubMed 32786601 · doi:10.1021/acs.est.0c02639
What was done
Computational molecular docking and molecular dynamics simulations were conducted on a dataset of over 4000 endocrine-disrupting chemicals (EDCs) to analyze structural determinants of binding and activation for estrogen receptor α (ERα) and androgen receptor (AR). Structure-function correlations were experimentally validated using a cell-free time-resolved fluorescence resonance energy-transfer (TR-FRET) assay.
What was found
The authors identified three structural tiers of chemical fragments controlling receptor interactions: primary fragments (20 for ERα, 18 for AR) and secondary fragments (38 for ERα, 29 for AR) determine receptor binding, while tertiary fragments determine functional modulation type (agonist, antagonist, or mixed). Quantitative binding affinities, sensitivity, and error metrics were not reported in the abstract.
Why it matters
The identified fragment hierarchy clarifies how structurally diverse environmental compounds engage ERα and AR, providing structural rules to accelerate high-throughput screening and risk profiling of commercial synthetic chemicals.
Limits
The findings rely entirely on computational modeling and in vitro assays; the abstract reports no in vivo validation, toxicokinetic data, or metabolic clearance considerations. Quantitative predictive accuracy, assay concentrations, and statistical performance metrics were omitted from the abstract.
Cited by
- supports Endocrine-disrupting chemicals interact directly with estrogen and androgen receptors, acting as anti-androgens or anti-estrogens by occupying receptor binding sites.